Liver disease is a major burden in the European region. It is a chronic condition affecting millions of European citizens, particularly those living in the new EU Member States and the most economically and socially disadvantaged. Liver cirrhosis kills 170,000 people per year in the region and there are 47,000 deaths from liver cancer. Fourteen million people are suffering from Hepatitis B and nine million from Hepatitis C.

To address the problems of liver disease in Europe, EASL recently held a side event during the EU Summit on Chronic Disease in Brussels on 3 April 2014. Entitled, “Putting Liver Disease at the Heart of EU Chronic Disease policy." Four speakers from the medical and patient communities gave an overview of the current burden of liver disease in the EU, effective prevention measures, innovative treatment strategies and remaining challenges to successfully tackle liver disease.

Download the final report from the event below, and view the presentations made available by the speakers:

  • Liver disease in the EU: Overall burden and social and economic costs. P. Burra
  • Risk factors for liver disease and how to prevent them. D. Valla
  • Treatment of liver disease. S. Fahey
  • Inequalities in the diagnosis and treatment of liver disease patients – The changes we need to see. A.Kautz, Policy Director of ELPA


EASL thanks Patrizia Burra, Dominique Valla, Siobhan Fahey, and Achim Kautz for their collaboration, and for generously sharing their presentations.


Documents to download

Final report from the meeting
Liver disease in the EU: Overall burden and social and economic costs. P. Burra
Risk factors for liver disease and how to prevent them. D. Valla
Treatment of liver disease. S. Fahey
Inequalities in the diagnosis and treatment of liver disease patients – The changes we need to see. A.Kautz Policy Director of ELPA